Results 51 to 60 of about 6,645 (198)
Long‐term use of lokivetmab in dogs with atopic dermatitis
Background – Lokivetmab, a caninised monoclonal antibody against interleukin (IL)‐31, is an effective treatment for the pruritus associated with canine atopic dermatitis (cAD). Objectives – To investigate the efficacy and safety of lokivetmab during long‐term treatment defined as at least three consecutive lokivetmab injections in atopic dogs under ...
Bettina Kasper +2 more
wiley +1 more source
Eventos adversos em pacientes cirúrgicos: Revisão integrativa
Objetivo: analisar as evidências científicas acerca dos eventos adversos ocorridos em pacientes cirúrgicos. Método: revisão integrativa de literatura, com coleta de dados de setembro a outubro de 2020, em três bases de dados: Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS), Medical Literature Analysis and Retrieval System Online ...
Andressa dos Santos +10 more
openaire +2 more sources
Applying the Estimand Framework to Non‐Inferiority Trials
ABSTRACT Most published applications of the estimand framework have focused on superiority trials. However, non‐inferiority trials present specific challenges compared to superiority trials. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use notes in their addendum on estimands and sensitivity ...
Helle Lynggaard +3 more
wiley +1 more source
Carfilzomib‐Induced Thrombotic Microangiopathy—Two Case Reports
ABSTRACTBackgroundThrombotic microangiopathy (TMA) is a pathological syndrome characterized by a combination of three key features: microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and organ damage, primarily affecting the kidneys. There are several drugs known to have a definite or probable causal association with TMA, and carfilzomib, a ...
Irene Attucci +7 more
wiley +1 more source
Background – Supplementation of polyunsaturated fatty acids (PUFA) enables dose reduction of prednisolone and ciclosporin in canine atopic dermatitis (cAD). Objective – To determine if oral administration of PUFA can reduce the dose of oclacitinib for cAD. Conclusion – Oral supplementation of PUFA allowed dose reduction of oclacitinib and improved pVAS,
Laura Schäfer, Nina Thom
wiley +1 more source
Rastreadores para a busca ativa de eventos adversos a medicamentos em recém-nascidos
O objetivo foi verificar a aplicação e o desempenho dos rastreadores para a busca ativa de eventos adversos a medicamentos em recém-nascidos hospitalizados. Trata-se de um estudo de coorte prospectivo.
Sandra de Carvalho Fabretti +3 more
doaj +1 more source
Eventos adversos pós-vacinais e resposta social [PDF]
A grande maioria das polêmicas públicas relativas a hipotéticos malefícios provocados pelas vacinas é extensão de controvérsias e discussões que surgem no próprio meio médico. Exemplos são os malefícios do mercúrio contido em várias vacinas, como a tríplice viral (MMR), provocando doença inflamatória intestinal e autismo; a vacina contra hepatite B e ...
Martins, Reinaldo Menezes +1 more
openaire +3 more sources
Relationship between two pathogens in an amphibian community that experienced mass mortalities
Abstract Because host species tend to harbor multiple parasitic species, coinfection in a host is common. The chytrid fungus Batrachochytrium dendrobatidis (Bd) and the viruses in the genus Ranavirus (Rv) are responsible for the decline of amphibians worldwide.
Barbora Thumsová +4 more
wiley +1 more source
Abstract Commonly identified patterns of psychological distress in response to adverse events are characterized by resilience (i.e., little to no distress), delayed (i.e., distress that increases over time), recovery (i.e., distress followed by a gradual decrease over time), and sustained (i.e., distress remaining stable over time). This study aimed to
Alba Contreras +17 more
wiley +1 more source
Subnotificação de eventos adversos ocasionados por medicamentos
Os eventos adversos causados por medicamento afetam a segurança do paciente nas instituições de saúde, com isso a notificação é um fator de compromisso por parte dos profissionais de saúde para reduzir a ocorrência de erros. O objetivo é analisar possíveis causas de subnotificação de eventos adversos ocasionados por medicamentos.
Abraão Santos Sousa +9 more
openaire +1 more source

